Skip to main content
SpringerLink
Log in

Akzelerierte versus konventionelle Fraktionierung bei der kombinierten Radiochemotherapie von Kopf-Hals-Tumoren

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24–35

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. Baujat B, Bourhis J, Blanchard P et al (2010) Hyperfractionated or accelerated radiotherapy for head and neck cancer. Cochrane Database Syst Rev 12:CD002026

    PubMed  Google Scholar 

  3. Becker-Schiebe M, Hoffmann W, Pinkert U et al (2008) Prognostic impact of p53 mutations and loss of heterozygosity at 9p21 and 11p15 in head and neck cancer. Trends Cancer Res 4:19–24

    CAS  Google Scholar 

  4. Beitler JJ, Zhang Q, Fu KK et al (2014) Final results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer. Int J Radiat Oncol Biol Phys 89(1):13–20

    Article  PubMed  Google Scholar 

  5. Bourhis J, Overgaard J, Audry H et al (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368:843–854

    Article  PubMed  Google Scholar 

  6. Bourhis J, Sire C, Graff P et al (2012) Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): an open-label phase 3 randomised trial. Lancet Oncol 13:145–153

    Article  PubMed  Google Scholar 

  7. Budach W, Hehr T, Budach V et al (2006) A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 6:28

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  8. Fu KK, Pajak TF, Trotti A et al (2000) A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48:7–16

    Article  CAS  PubMed  Google Scholar 

  9. Pignon JP, le Maître A, Maillard E et al (2009) Metaanalysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 92:4–14

    Article  PubMed  Google Scholar 

  10. Rischin D, Young R, Fisher R et al (2010) Prognostic significance of p16 INK4A and HPF in patients with oropharyngeal cancer treated on TROG 0202 Phase III Trial. J Clin Oncol 28:4142–4148

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Radioonkologie und Strahlentherapie, Celler Str. 38, 38114, Braunschweig, Deutschland

    Martina Becker-Schiebe

  2. Strahlentherapie und Spezielle Onkologie, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland,

    Hans Christiansen

Authors
  1. Martina Becker-Schiebe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans Christiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Martina Becker-Schiebe.

Ethics declarations

Interessenkonflikt

M. Becker-Schiebe und H. Christiansen geben an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Becker-Schiebe, M., Christiansen, H. Akzelerierte versus konventionelle Fraktionierung bei der kombinierten Radiochemotherapie von Kopf-Hals-Tumoren. Strahlenther Onkol 191, 384–386 (2015). https://doi.org/10.1007/s00066-015-0819-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-015-0819-1

Search

Navigation